The Meteoritics Trial: efficacy of methotrexate after remission-induction with tocilizumab and glucocorticoids in giant cell arteritis-study protocol for a randomized, double-blind, placebo-controlled, parallel-group phase II study.
Lena KreisChristian DejacoWolfgang Andreas SchmidtRobert NémethNils VenhoffValentin Sebastian SchäferPublished in: Trials (2024)
ClinicalTrials.gov, NCT05623592. Registered on 21 November 2022. EU Clinical Trials Register, 2022-501058-12-00. German Clinical Trials Register DRKS00030571.
Keyphrases
- placebo controlled
- phase ii study
- clinical trial
- double blind
- giant cell
- phase iii
- phase ii
- open label
- study protocol
- rheumatoid arthritis
- disease activity
- juvenile idiopathic arthritis
- radiation therapy
- locally advanced
- rheumatoid arthritis patients
- squamous cell carcinoma
- randomized controlled trial
- low dose
- ulcerative colitis